1) fluid therapy
液体治疗
1.
Objective: To investigate the correlation between intraoperative and postoperative fluid therapy and postoperative early pulmonary complication,and to provide the reasonable fluid therapy measures for the perioperative period.
目的探讨肝移植术中、术后的液体治疗与术后早期肺部并发症的关系,为肝移植围手术期合理的液体治疗提供依据。
2.
Objective: To study the time course of distribution and elimination with model of volume kinetics and mass balance during fluid infusion in different situation, and to try to design and optimize fluid therapy in a more scientific fashion.
液体动力学优化液体治疗的临床与实验研究 目的：应用液体动力学的数学模型和物质守恒定律动态分析不同病理生理条件下液体在体内的分布、排泄的时间过程，为临床合理的液体治疗提供理论依据。
3.
Objective: To investigate the correlation between intraoperative and postoperative fluid therapy and postoperative early complication, then according to the investigation, to provide the reasonable fluid therapy measure for the perioperative period.
目的:探讨肝移植术中、术后的液体治疗与术后早期并发症的关系,为肝移植围手术期合理的液体治疗提供依据。
2) Early fluid therapy
早期液体治疗
1.
Conclusion Early fluid therapy on acute pancreatitis,especially negative balance of fluid therapy,can effectively prevent acute pancreatitis from aggravation, it can reduce complications and mortality,and improves the prognosis.
目的探讨早期液体治疗对急性胰腺炎预后的影响。
4) Substitution transfusion
血液治疗
6) mucinous/therapy
粘液/治疗
补充资料：1,2-二甲基环氧乙烷(1,2-dimethylethylene oxide)无色液体
分子式：
CAS号：
性质：又称1,2-二甲基环氧乙烷(1,2-dimethylethylene oxide)无色液体。沸点56～57℃,相对密度0.8344。有醚的气味,易挥发。易燃。微溶于水,可溶于乙醇、乙醚等有机溶剂。有环氧化物的一般性质。由3-氯2-丁醇或3-溴-2-丁醇与氢氧化钠或碳酸钾反应制得。用作有机合成的中间体。
CAS号：
性质：又称1,2-二甲基环氧乙烷(1,2-dimethylethylene oxide)无色液体。沸点56～57℃,相对密度0.8344。有醚的气味,易挥发。易燃。微溶于水,可溶于乙醇、乙醚等有机溶剂。有环氧化物的一般性质。由3-氯2-丁醇或3-溴-2-丁醇与氢氧化钠或碳酸钾反应制得。用作有机合成的中间体。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条